BIOA INVESTOR DEADLINE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
Aurora Labs Launches Aurora Cloud Console, The Self-Serve Zero Coding Platform To Build Custom Blockchains
Gibraltar, British Overseas Territories, January 16th, 2025, ChainwireAurora Labs has announced the launch of the Aurora ...
Aspargo Labs Aims For Direct Listing On Little Revenue
Aspargo Labs aims for a direct listing despite minimal revenue, significant losses, and high cash burn. Click here to read an ...
Nvidia, Broadcom, Marvell Positioned For Growth As AI Demand Drives Semiconductor Momentum
Analyst N. Quinn Bolton notes 2024's divergence in fortunes for semiconductor companies exposed to different end markets. AI ...